Navigation Links
Nano Mask Enters Into Five Year $13,000,000 Middle East Distribution Agreement with Tamayz Medical
Date:3/29/2012

FISHKILL, N.Y., March 29, 2012 /PRNewswire/ -- Nano Mask Inc., (NMI) (NANM.PK), a materials technology development company focused on health and wellness related markets, today announced that it has entered into a five year distribution agreement with Tamayz Medical, Inc. (the distributor), a Middle Eastern medical products distributor based in Riyadh, Saudi Arabia . Tamayz has agreed to purchase a minimum of $13,000,000 of various NMI healthcare products fabricated with X-Static® antimicrobial yarn over five years in exchange for exclusive distribution rights in the Middle East.  The agreement has a five year renewal option.

This agreement is separate from a previous distribution agreement with Tamayz which called for the purchase of $ 2,300,000 in NMI products over four years.  In total, agreements with the distributor call for the purchase of a minimum of $15,300,000 of NMI products within five years.

The agreement calls for NMI to supply to the following products:  hospital and surgical scrubs, patient gowns and pajamas, bedding (sheets, pillows, covers and liners), blankets, window and cubicle curtains, as well as X-Static Silver yarn fabric. The territory governed by the agreement includes the following countries: Saudi Arabia, Egypt, Libya, Algeria, Morocco, Jordan, Iraq, Lebanon, Bahrain, Yemen, Kuwait, Oman, Qatar and United Arab Emirates.

"We have been working diligently with our Saudi partners to form this strategic relationship, by establishing not only an office in Saudi Arabia, but also facilitating the manufacture of our products in that country."

Mr. Suydam added, "We are confident that our partners will meet or exceed the minimum sales requirements outlined in our agreement, as evidenced by the significant orders from the Middle East that we have already received."

About Nano Mask

Nano Mask Inc. (NMI) is a materials technology development, manufacturing and distribution company providing emergency life support and infection prevention products and solutions to a variety of market segments within the healthcare industry.

Forward-looking Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.

For further Information email:
Edward J. Suydam
President and CEO
Nano Mask Inc.
Eds@nmihealth.com
914-760-7857


'/>"/>
SOURCE Nano Mask Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
2. Brainlab Partners With Radion to Integrate VoyantLink Image Sharing Into One Streamlined Solution for Radiation Therapy Centers
3. Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV
4. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
5. In 50th Anniversary Year, Northwest Kidney Centers Gives Clyde Shields Distinguished Service Award to All Its Dialysis Patients
6. National Data Center Hosting Provider, CoreLink Data Centers, to Present at HIMSS 2012
7. Anlit Enters Polish Market with New Food Supplements for Kids
8. Viztek Launches ViZion DR Rad Room Straight Arm - Cost Effective Solution Ideal for Imaging Centers, Urgent Care, and Private Practice
9. Innocoll Enters CollaGUARD® Distribution Partnership With Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany
10. RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers
11. Morphotek Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the "Contraceptives - ... ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)... 2017  Ethicon, Inc. today announced a definitive ... held medical device company that manufactures and markets ... novel minimally invasive device for the surgical treatment ... enable Ethicon to offer patients a safe and ... surgical procedure. 1 This LINX ...
(Date:2/17/2017)... Theravance Biopharma, Inc. (NASDAQ: ... announced the presentation of positive clinical data for ... kinase (JAK) inhibitor designed to be intestinally restricted, ... European Crohn,s and Colitis Organization (ECCO). In a ... its completed Phase 1 study of single-ascending and ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... not kept pace. Enovate Medical has introduced an innovative workstation designed to reduce ... supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional ...
(Date:2/17/2017)... ... 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, a ... non-controlled substances plus the ability to manage orders on their desktop or mobile ... electronic prescriptions, according to the Office of the National Coordinator of Health IT, ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ... manufacturers should be asking before selecting an FDA approval pathway? , How ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... February 17, ... ... Devices, Implementing the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. ... , Do manufacturers distinguish between corrective action (CA) and preventive action ...
Breaking Medicine News(10 mins):